StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb (BMY) Responded to Starboard's Letter, Confident in Combination with Celgene (CELG)
February 28, 2019 12:00 PM
Bristol-Myers Squibb Company (NYSE: BMY) today issued the following statement in response to a letter from Starboard Value: Bristol-Myers Squibb ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Hedge Funds
Management Comments
Mergers and Acquisitions
Next Articles
Bristol-Myers Squibb Issues Statement in Response to Starboard’s Letter
February 28, 2019 11:59 AM
Starboard Value says Bristol-Myers Squibb's (BMY) proposed merger with Celgene (CELG) is ill-advised
February 28, 2019 9:42 AM
Starboard Delivers Open Letter to Bristol-Myers Squibb Stockholders
February 28, 2019 9:40 AM
